Another study also implicated leptin in the early stages of breast cancer, showing that leptin treatment promotes epithelial-mesenchymal transition through activation of the kinases Src and FAK in MCF10A cells, a non-cancerous mammary epithelial cell line, which led to enhanced invasion through Matrigel (80). Here, LEP is linked to breast cancer.